Back to funds

Atlas Venture Life Science Advisors, LLC

hedge fundUpdated 12 days ago

Managed by Atlas Venture Life Science Advisors, Llc • Latest filing Q3 2026

Portfolio value
$631.2M
Q3 2026
Filings
5
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 5 quarters

Show data table
PeriodPortfolio value
Q3 2025$752.6M
Q4 2025$865.2M
Q1 2026$790M
Q2 2026$881.3M
Q3 2026$631.2M

Top holdings

9 positions as of Q3 2026

View filing
K

Kymera Therapeutics, Inc.

Value
$318.3M
Shares
2.85M
% Port
50.43%
I

Disc Medicine, Inc.

Value
$90.6M
Shares
1.38M
% Port
14.35%
O

Obsidian Therapeutics, Inc.

Value
$61.8M
Shares
4.50M
% Port
9.80%
K

Kailera Therapeutics, Inc.

Value
$59.1M
Shares
5.17M
% Port
9.36%
D

Dyne Therapeutics, Inc.

Value
$55.4M
Shares
3.44M
% Port
8.78%
Q

Q32 Bio, Inc.

Value
$22.5M
Shares
2.72M
% Port
3.56%
S

Sionna Therapeutics, Inc.

Value
$15.8M
Shares
3.00M
% Port
2.50%
K

Korro Bio, Inc.

Value
$7.7M
Shares
773.3K
% Port
1.21%
O

Odyssey Therapeutics, Inc.

Value
$60K
Shares
2.7K
% Port
0.01%

Explore